SEC Form 5 · accession 0001387131-15-000204
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Orin Hirschman
Director
Period of report
Sep 30, 2014
Accepted (ET)
Jan 23, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 per shareF1,F2,F3 | Apr 30, 2014 | G | 23,300 | $0.00 | D | 1,673,948 | I | By AIGH |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, purchase options | $1.71 | holding | — | — | — | Jan 23, 2015 | Mar 9, 2017 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1On April 30, 2014, the reporting person made a gift of 2,900 shares to each of eight minor children in custodial accounts with himself as custodian. These shares are included in his beneficial ownership above.
- F2Includes options and warrants.
- F3Includes shares and warrants owned indirectly through AIGH Investment Partners LLC ("AIGH") and custodial accounts for Mr. Hirschman's children. Mr. Hirschman is the sole member of AIGH and is solely responsible for investment and voting decisions. Includes options owned directly by Mr. Hirshman.